Pathways linking microbiota-gut-brain axis with neuroinflammatory mechanisms in Alzheimer’s pathophysiology

Abstract

Disturbances in the local and peripheral immune systems are closely linked to a wide range of diseases. In the context of neurodegenerative disorders such as Alzheimer’s disease (AD), inflammation plays a crucial role, often appearing as a common manifestation despite the variability in the occurrence of other pathophysiological hallmarks. Thus, combating neuroinflammation holds promise in treating complex pathophysiological diseases like AD. Growing evidence suggests the gut microbiome’s crucial role in shaping the pathogenesis of AD by influencing inflammatory mediators. Gut dysbiosis can potentially activate neuroinflammatory pathways through bidirectional signaling of the gut-brain axis; however, the precise mechanisms of this complex interweaved network remain largely unclear. In these milieus, this review attempts to summarize the contributing role of gut microbiome-mediated neuroinflammatory signals in AD pathophysiology, while also pondering potential mechanisms through which commensal and pathogenic gut microbes affect neuroinflammation. While certain taxa such as Roseburia and Escherichia have been strongly correlated with AD, other clades such as Bacteroides and Faecalibacterium exhibit variations at the species and strain levels. In order to disentangle the inflammatory aspects of neurodegeneration attributed to the gut microbiome, it is imperative that future mechanistic studies investigate the species/strain-level dependency of commensals, opportunistic, and pathogenic gut microbes that consistently show correlations with AD patients across multiple associative studies.

Keywords

Neurodegeneration / neuroinflammation / gut dysbiosis / inflammatory cytokines / microbiota-gut-brain axis / microglia activation

References

[1] Sochocka M,Diniz BS,Brzozowska E.The gut microbiome alterations and inflammation-driven pathogenesis of Alzheimer’s disease - a critical review.Mol Neurobiol2019;56:1841-51 PMCID:PMC6394610

[2] Alam R,Zhou JR.Microbiome, inflammation, epigenetic alterations, and mental diseases.Am J Med Genet B Neuropsychiatr Genet2017;174:651-60 PMCID:PMC9586840

[3] Askarova S,Masoud AR.The links between the gut microbiome, aging, modern lifestyle and Alzheimer’s disease.Front Cell Infect Microbiol2020;10:104 PMCID:PMC7093326

[4] Santiago JA.The impact of disease comorbidities in Alzheimer’s disease.Front Aging Neurosci2021;13:631770 PMCID:PMC7906983

[5] Leng F,Gentleman S.Neuroinflammation is independently associated with brain network dysfunction in Alzheimer’s disease.Mol Psychiatry2023;28:1303-11 PMCID:PMC10005956

[6] Griciuc A,Parrado AR.Alzheimer’s disease risk gene CD33 inhibits microglial uptake of amyloid beta.Neuron2013;78:631-43 PMCID:PMC3706457

[7] Leng F.Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?.Nat Rev Neurol2021;17:157-72

[8] Dai CL,Iqbal K.Gut microbiota and immunotherapy for Alzheimer’s disease.Int J Mol Sci2022;23:15230 PMCID:PMC9741026

[9] Bhattacharjee S.Alzheimer’s disease and the microbiome.Front Cell Neurosci2013;7:153 PMCID:PMC3775450

[10] WHO. Dementia. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia. [Last accessed on 4 Dec 2023]

[11] Alzheimer’s Disease International. World Alzheimer Report 2022: Life after diagnosis: navigating treatment, care and support. Available from: https://www.alzint.org/resource/world-alzheimer-report-2022/. [Last accessed on 4 Dec 2023]

[12] Frisoni GB,Thal DR.The probabilistic model of Alzheimer disease: the amyloid hypothesis revised.Nat Rev Neurosci2022;23:53-66 PMCID:PMC8840505

[13] Hoe HS,Pak DT.The upside of APP at synapses.CNS Neurosci Ther2012;18:47-56 PMCID:PMC3116065

[14] Duka V,Credle J.Identification of the sites of tau hyperphosphorylation and activation of tau kinases in synucleinopathies and Alzheimer’s diseases.PLoS One2013;8:e75025 PMCID:PMC3779212

[15] Lin L,Zhang LJ.Neuroinflammation, gut microbiome, and Alzheimer’s disease.Mol Neurobiol2018;55:8243-50

[16] Yang Y,Wang J.Arglabin regulates microglia polarization to relieve neuroinflammation in Alzheimer’s disease.J Biochem Mol Toxicol2022;36:e23045

[17] Zhang Y.Relation of CDC42, Th1, Th2, and Th17 cells with cognitive function decline in Alzheimer’s disease.Ann Clin Transl Neurol2022;9:1428-36 PMCID:PMC9463943

[18] Halle A,Petzold GC.The NALP3 inflammasome is involved in the innate immune response to amyloid-β.Nat Immunol2008;9:857-65 PMCID:PMC3101478

[19] Thakur S,Sarma P,Reddy DH.Neuroinflammation in Alzheimer’s disease: current progress in molecular signaling and therapeutics.Inflammation2023;46:1-17

[20] Dubenko OE,Potapov OO.Levels of proinflammatory cytokines IL-17 and IL-23 in patients with Alzheimer’s disease, mild cognitive impairment and vascular dementia.Wiad Lek2021;74:68-71

[21] Dong Y,Li X.Hyperphosphorylated tau mediates neuronal death by inducing necroptosis and inflammation in Alzheimer’s disease.J Neuroinflammation2022;19:205 PMCID:PMC9377071

[22] Doulberis M,Thomann R.Review: Impact of Helicobacter pylori on Alzheimer’s disease: what do we know so far?.Helicobacter2018;23:e12454

[23] Koenigsknecht-Talboo J.Microglial phagocytosis induced by fibrillar beta-amyloid and IgGs are differentially regulated by proinflammatory cytokines.J Neurosci2005;25:8240-9 PMCID:PMC6725530

[24] Ganguly U,Chakrabarti SS.Oxidative stress, neuroinflammation, and NADPH oxidase: implications in the pathogenesis and treatment of Alzheimer’s disease.Oxid Med Cell Longev2021;2021:7086512 PMCID:PMC8068554

[25] Browne TC,McManus RM,Mills KHG.IFN-γ production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer’s disease.J Immunol2013;190:2241-51

[26] Westermann J.How organ-specific is the migration of 'naive' and 'memory' T cells?.Immunol Today1996;17:278-82

[27] Satarkar D.Evolution, expression and functional analysis of CXCR3 in neuronal and cardiovascular diseases: a narrative review.Front Cell Dev Biol2022;10:882017 PMCID:PMC9252580

[28] Ye X,Pan J.Interleukin-17 promotes the infiltration of CD8+ T cells into the brain in a mouse model for Alzheimer’s disease.Immunol Invest2023;52:135-53

[29] Cristiano C,Lippiello P.Neutralization of IL-17 rescues amyloid-β-induced neuroinflammation and memory impairment.Br J Pharmacol2019;176:3544-57 PMCID:PMC6715610

[30] Effendi RMRA,Kalim H.Akkermansia muciniphila and Faecalibacterium prausnitzii in immune-related diseases.Microorganisms2022;10:2382 PMCID:PMC9782003

[31] Masuda T,Staszewski O.Microglia heterogeneity in the single-cell era.Cell Rep2020;30:1271-81

[32] Kubick N,Klimovich P,Mickael ME.What has single-cell RNA sequencing revealed about microglial neuroimmunology?.Immun Inflamm Dis2020;8:825-39 PMCID:PMC7654416

[33] Keren-Shaul H,Weiner A.A unique microglia type associated with restricting development of Alzheimer’s disease.Cell2017;169:1276-90.e17

[34] Zhou Y,Andhey PS.Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease.Nat Med2020;26:131-42

[35] Srinivasan K,Etxeberria A.Alzheimer’s patient microglia exhibit enhanced aging and unique transcriptional activation.Cell Rep2020;31:107843 PMCID:PMC7422733

[36] Mathys H,Gao F.Temporal tracking of microglia activation in neurodegeneration at single-cell resolution.Cell Rep2017;21:366-80 PMCID:PMC5642107

[37] Olah M,Habib N.Single cell RNA sequencing of human microglia uncovers a subset associated with Alzheimer’s disease.Nat Commun2020;11:6129

[38] Huang Y,Zhang H.The gut microbiome modulates the transformation of microglial subtypes.Mol Psychiatry2023;28:1611-21 PMCID:PMC10208978

[39] Nguyen VTT.A crate of Pandora: do amyloids from bacteria promote Alzheimer’s disease?.Neural Regen Res2021;16:988-9 PMCID:PMC8178769

[40] Xiao L,Zheng J,Zhao F.Deterministic transition of enterotypes shapes the infant gut microbiome at an early age.Genome Biol2021;22:243 PMCID:PMC8383385

[41] Bonsack B,Borlongan CV.A gut feeling about stroke reveals gut-brain axis’ active role in homeostasis and dysbiosis.J Cereb Blood Flow Metab2020;40:1132-4 PMCID:PMC7181096

[42] Seguella L,Esposito G.Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s disease.Neural Regen Res2020;15:1037-8 PMCID:PMC7034261

[43] Giridharan VV,Catalão CHR.Sepsis exacerbates Alzheimer’s disease pathophysiology, modulates the gut microbiome, increases neuroinflammation and amyloid burden. Mol Psychiatry 2023.

[44] Edwards LA,Edwards EA.Aberrant response to commensal Bacteroides thetaiotaomicron in Crohn’s disease: an ex vivo human organ culture study.Inflamm Bowel Dis2011;17:1201-8

[45] Angiulli F,Zoia CP.Blood-based biomarkers of neuroinflammation in Alzheimer’s disease: a central role for periphery?.Diagnostics2021;11:1525 PMCID:PMC8464786

[46] Walker KA,Folsom AR.Midlife systemic inflammatory markers are associated with late-life brain volume: the ARIC study.Neurology2017;89:2262-70

[47] Lancaster TM,Sims R.Microglia - mediated immunity partly contributes to the genetic association between Alzheimer’s disease and hippocampal volume.Brain Behav Immun2019;79:267-73 PMCID:PMC6605284

[48] Dodiya HB,Shaik SM.Sex-specific effects of microbiome perturbations on cerebral Aβ amyloidosis and microglia phenotypes.J Exp Med2019;216:1542-60 PMCID:PMC6605759

[49] Dodiya HB,Weigle IQ.Gut microbiota-driven brain Aβ amyloidosis in mice requires microglia.J Exp Med2022;219:e20200895 PMCID:PMC8647415

[50] Chandra S,Dodiya HB.The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms. Mol Neurodegener 2023;18:45. PMCID:PMC10324210

[51] Kim MS,Choi H.Transfer of a healthy microbiota reduces amyloid and tau pathology in an Alzheimer’s disease animal model.Gut2020;69:283-94

[52] Cammann D,Cummings MJ.Genetic correlations between Alzheimer’s disease and gut microbiome genera.Sci Rep2023;13:5258 PMCID:PMC10066300

[53] Vogt NM,Dill-McFarland KA.Gut microbiome alterations in Alzheimer’s disease.Sci Rep2017;7:13537 PMCID:PMC5648830

[54] Yıldırım S,Bayraktar A.stratification of the gut microbiota composition landscape across the Alzheimer’s disease continuum in a turkish cohort.mSystems2022;7:e0000422 PMCID:PMC8823292

[55] Nagpal R,Wang S,Yadav H.Modified Mediterranean-ketogenic diet modulates gut microbiome and short-chain fatty acids in association with Alzheimer’s disease markers in subjects with mild cognitive impairment.EBioMedicine2019;47:529-42 PMCID:PMC6796564

[56] Hollander D.The “Leaky Gut”: tight junctions but loose associations?.Dig Dis Sci2020;65:1277-87 PMCID:PMC7193723

[57] Chen C,Xia Y.Gut microbiota regulate Alzheimer’s disease pathologies and cognitive disorders via PUFA-associated neuroinflammation.Gut2022;71:2233-52

[58] Kim DS,Ryuk JA.Tetragonia tetragonioides protected against memory dysfunction by elevating hippocampal amyloid-β deposition through potentiating insulin signaling and altering gut microbiome composition.Int J Mol Sci2020;21:2900 PMCID:PMC7216031

[59] Zhan X,Sharp FR.Lipopolysaccharide associates with amyloid plaques, neurons and oligodendrocytes in Alzheimer’s disease brain: a review.Front Aging Neurosci2018;10:42 PMCID:PMC5827158

[60] Zhao Y,Lukiw WJ.Secretory products of the human GI tract microbiome and their potential impact on Alzheimer’s disease (AD): detection of lipopolysaccharide (LPS) in AD hippocampus.Front Cell Infect Microbiol2017;7:318 PMCID:PMC5504724

[61] Zhao Y,Jaber V.Microbiome-derived lipopolysaccharide enriched in the perinuclear region of Alzheimer’s disease brain.Front Immunol2017;8:1064 PMCID:PMC5591429

[62] Muhammad T,Ullah R,Kim MO.Hesperetin, a citrus flavonoid, attenuates LPS-induced neuroinflammation, apoptosis and memory impairments by modulating TLR4/NF-κB signaling.Nutrients2019;11:648 PMCID:PMC6471991

[63] Salvi PS.Butyrate and the intestinal epithelium: modulation of proliferation and inflammation in homeostasis and disease.Cells2021;10:1775 PMCID:PMC8304699

[64] Matt SM,Lawson MA,Woods JA.Butyrate and dietary soluble fiber improve neuroinflammation associated with aging in mice.Front Immunol2018;9:1832 PMCID:PMC6102557

[65] Liu J,Gong T.Anti-neuroinflammatory effect of short-chain fatty acid acetate against Alzheimer’s disease via upregulating GPR41 and inhibiting ERK/JNK/NF-κB.J Agric Food Chem2020;68:7152-61

[66] Reisenauer CJ,Mitteness DJ.Acetate supplementation attenuates lipopolysaccharide-induced neuroinflammation.J Neurochem2011;117:264-74 PMCID:PMC3070819

[67] Luqman A,Nguyen MT,Götz F.SadA-expressing staphylococci in the human gut show increased cell adherence and internalization.Cell Rep2018;22:535-45

[68] Chen Y,Chen Y.Regulation of neurotransmitters by the gut microbiota and effects on cognition in neurological disorders.Nutrients2021;13:2099 PMCID:PMC8234057

[69] Qian XH,Liu XL,Tang HD.Inflammatory pathways in Alzheimer’s disease mediated by gut microbiota.Ageing Res Rev2021;68:101317

[70] Goyal D,Singh RK.Emerging role of gut microbiota in modulation of neuroinflammation and neurodegeneration with emphasis on Alzheimer’s disease.Prog Neuropsychopharmacol Biol Psychiatry2021;106:110112

[71] Wu L,Zheng Z.Altered gut microbial metabolites in amnestic mild cognitive impairment and Alzheimer’s disease: signals in host-microbe interplay.Nutrients2021;13:228 PMCID:PMC7829997

[72] Desbonnet L,Clarke G,Cryan JF.Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression.Neuroscience2010;170:1179-88

[73] Desbonnet L,Clarke G,Dinan TG.The probiotic Bifidobacteria infantis: an assessment of potential antidepressant properties in the rat.J Psychiatr Res2008;43:164-74

[74] Pappolla MA,Fang X,Sambamurti K.Indoles as essential mediators in the gut-brain axis. Their role in Alzheimer’s disease.Neurobiol Dis2021;156:105403

[75] Chyan YJ,Omar RA.Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid.J Biol Chem1999;274:21937-42

[76] Rothhammer V,Bunse L.Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor.Nat Med2016;22:586-97 PMCID:PMC4899206

[77] Lin J,Cui C.The therapeutic potential of diet on immune-related diseases: based on the regulation on tryptophan metabolism.Crit Rev Food Sci Nutr2022;62:8793-811

[78] Oren A.Valid publication of the names of forty-two phyla of prokaryotes.Int J Syst Evol Microbiol2021;71:005056

[79] Shin NR,Bae JW.Proteobacteria: microbial signature of dysbiosis in gut microbiota.Trends Biotechnol2015;33:496-503

[80] Liu P,Peng G.Altered microbiomes distinguish Alzheimer’s disease from amnestic mild cognitive impairment and health in a Chinese cohort.Brain Behav Immun2019;80:633-43

[81] Lu S,Xu Q.Gut microbiota and targeted biomarkers analysis in patients with cognitive impairment.Front Neurol2022;13:834403 PMCID:PMC8891499

[82] Li B,Ma J.Mild cognitive impairment has similar alterations as Alzheimer’s disease in gut microbiota.Alzheimers Dement2019;15:1357-66

[83] Zhou Y,Quan M,Jia J.Gut microbiota changes and their correlation with cognitive and neuropsychiatric symptoms in Alzheimer’s disease.J Alzheimers Dis2021;81:583-95

[84] Wang Y,Zhao X.Intestinal microflora changes in patients with mild Alzheimer’s disease in a Chinese cohort.J Alzheimers Dis2022;88:563-75

[85] Cattaneo A,Galluzzi S.INDIA-FBP GroupAssociation of brain amyloidosis with pro-inflammatory gut bacterial taxa and peripheral inflammation markers in cognitively impaired elderly.Neurobiol Aging2017;49:60-8

[86] Wanapaisan P,Nopnipa S.Association between gut microbiota with mild cognitive impairment and Alzheimer’s disease in a Thai population.Neurodegener Dis2022;22:43-54

[87] Zhuang ZQ,Li WW.Gut microbiota is altered in patients with Alzheimer’s disease.J Alzheimers Dis2018;63:1337-46

[88] Kang DJ,Ghosh SA.Gut microbiota drive the development of neuroinflammatory response in cirrhosis in mice.Hepatology2016;64:1232-48 PMCID:PMC5033692

[89] Xia Y,Fang X,Han L.Combined analysis of metagenomic data revealed consistent changes of gut microbiome structure and function in inflammatory bowel disease.J Appl Microbiol2021;131:3018-31

[90] Ng A,Zhang MW.IL-1β, IL-6, TNF- α and CRP in elderly patients with depression or Alzheimer’s disease: systematic review and meta-analysis.Sci Rep2018;8:12050

[91] Burke SJ,Sparer TE.NF-κB and STAT1 control CXCL1 and CXCL2 gene transcription.Am J Physiol Endocrinol Metab2014;306:E131-49 PMCID:PMC3920007

[92] Bryant AG,Carlyle BC.Cerebrovascular senescence is associated with tau pathology in Alzheimer’s disease.Front Neurol2020;11:575953 PMCID:PMC7525127

[93] Vallès A,de Bree FM,Ronken E.Differential regulation of the CXCR2 chemokine network in rat brain trauma: implications for neuroimmune interactions and neuronal survival.Neurobiol Dis2006;22:312-22

[94] Bessho S,Kyrylchuk K.Systemic exposure to bacterial amyloid curli alters the gut mucosal immune response and the microbiome, exacerbating Salmonella-induced arthritis.Gut Microbes2023;15:2221813 PMCID:PMC10269392

[95] Biesecker SG,Wilson RP.The functional amyloid curli protects escherichia coli against complement-mediated bactericidal activity.Biomolecules2018;8:5 PMCID:PMC5871974

[96] Bhoite SS,Ruotolo BT.Mechanistic insights into accelerated α-synuclein aggregation mediated by human microbiome-associated functional amyloids.J Biol Chem2022;298:102088 PMCID:PMC9253359

[97] Thomas F,Rebuffet E,Michel G.Environmental and gut bacteroidetes: the food connection.Front Microbiol2011;2:93 PMCID:PMC3129010

[98] Saji N,Hisada T.The relationship between the gut microbiome and mild cognitive impairment in patients without dementia: a cross-sectional study conducted in Japan.Sci Rep2019;9:19227 PMCID:PMC6920432

[99] Stadlbauer V,Komarova I.Dysbiosis, gut barrier dysfunction and inflammation in dementia: a pilot study.BMC Geriatr2020;20:248 PMCID:PMC7372911

[100] Ubeda C,Luque-Tirado A.Fecal volatile organic compounds and microbiota associated with the progression of cognitive impairment in Alzheimer’s disease.Int J Mol Sci2022;24:707 PMCID:PMC9821163

[101] Verhaar BJH,de Leeuw FA.Gut microbiota composition is related to AD pathology.Front Immunol2022;12:794519

[102] Aljumaah MR,Roach J,Azcarate Peril MA.The gut microbiome, mild cognitive impairment, and probiotics: a randomized clinical trial in middle-aged and older adults.Clin Nutr2022;41:2565-76

[103] Sitkin S.Clinical potential of anti-inflammatory effects of faecalibacterium prausnitzii and butyrate in inflammatory bowel disease.Inflamm Bowel Dis2019;25:e40-1

[104] Alvarez CA,Hambor J.Characterization of polysaccharide A response reveals interferon responsive gene signature and immunomodulatory marker expression.Front Immunol2020;11:556813 PMCID:PMC7649347

[105] De Filippo C,Di Paola M.Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa.Proc Natl Acad Sci U S A2010;107:14691-6 PMCID:PMC2930426

[106] Sun Y,Nie Q.Gut firmicutes: relationship with dietary fiber and role in host homeostasis.Crit Rev Food Sci Nutr2022;1-16

[107] Soriano M,Taddei A,Grandi G.Group B Streptococcus crosses human epithelial cells by a paracellular route.J Infect Dis2006;193:241-50

[108] Duan M,Fu H,Wang T.Preoperative microbiomes and intestinal barrier function can differentiate prodromal Alzheimer’s disease from normal neurocognition in elderly patients scheduled to undergo orthopedic surgery.Front Cell Infect Microbiol2021;11:592842 PMCID:PMC8044800

[109] Sheng C,Lin H,Han Y.Altered gut microbiota in adults with subjective cognitive decline: the SILCODE study.J Alzheimers Dis2021;82:513-26

[110] Magne F,Gauthier L.The firmicutes/bacteroidetes ratio: a relevant marker of gut dysbiosis in obese patients?.Nutrients2020;12:1474 PMCID:PMC7285218

[111] Ling Z,Yan X.Structural and functional dysbiosis of fecal microbiota in Chinese patients with Alzheimer’s disease.Front Cell Dev Biol2020;8:634069 PMCID:PMC7889981

[112] Xi J,Zhu H.Disturbed microbial ecology in Alzheimer’s disease: evidence from the gut microbiota and fecal metabolome.BMC Microbiol2021;21:226 PMCID:PMC8361629

[113] Chen XX,Cai D,Wang YJ.Correlation between APOE4 gene and gut microbiota in Alzheimer’s disease.Benef Microbes2023;14:349-60

[114] Botchway BO,Chen Y,Fang M.Alzheimer disease: recent updates on apolipoprotein E and gut microbiome mediation of oxidative stress, and prospective interventional agents.Aging Dis2022;13:87-102 PMCID:PMC8782546

[115] Stražar M,Koeken VACM.The influence of the gut microbiome on BCG-induced trained immunity.Genome Biol2021;22:275 PMCID:PMC8456614

[116] Song L,Zheng H.Roseburia hominis alleviates neuroinflammation via short-chain fatty acids through histone deacetylase inhibition.Mol Nutr Food Res2022;66:e2200164 PMCID:PMC9787297

[117] Wang X,Feng T.Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression.Cell Res2019;29:787-803 PMCID:PMC6796854

[118] Martynyuk AE,Sumners C,Dennis DM.Impaired glutamatergic synaptic transmission in the PKU brain.Mol Genet Metab2005;86 Suppl 1:S34-42

[119] Liu P,Yu N.Phenylalanine metabolism is dysregulated in human hippocampus with Alzheimer’s disease related pathological changes.J Alzheimers Dis2021;83:609-22

[120] Rao X,Zhang L.Dual roles of interleukin-33 in cognitive function by regulating central nervous system inflammation.J Transl Med2022;20:369 PMCID:PMC9382782

[121] Wrzosek L,Noordine ML.Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent.BMC Biol2013;11:61 PMCID:PMC3673873

[122] Kountouras J,Gavalas E.Relationship between Helicobacter pylori infection and Alzheimer disease.Neurology2006;66:938-40

[123] Chang YP,Kuo FC.Eradication of Helicobacter pylori is associated with the progression of dementia: a population-based study.Gastroenterol Res Pract2013;2013:175729

[124] Holmes C.Role of infection in the pathogenesis of Alzheimer’s disease: implications for treatment.CNS Drugs2009;23:993-1002

[125] Allen HB.Alzheimer’s disease: assessing the role of spirochetes, biofilms, the immune system, and amyloid-β with regard to potential treatment and prevention.J Alzheimers Dis2016;53:1271-6 PMCID:PMC5008232

[126] Miklossy J.Historic evidence to support a causal relationship between spirochetal infections and Alzheimer’s disease.Front Aging Neurosci2015;7:46 PMCID:PMC4399390